 SAN DIEGO and CALGARY, AB, March 10, 2021 PRNewswire -- Oncolytics Biotech Inc. NASDAQ: ONCY TSX: ONC today announced that it will present updated clinical data from its AWARE-1 window-of-opportunity study in patients with early-stage breast cancer, as well as results from preclinical studies evaluating pelareorep-based combination therapies, in poster presentations during Week 1 of the American Association for Cancer Research AACR Annual Meeting 2021, taking place virtually from April 10-15, 2021. Details on the posters and corresponding abstracts are shown below. 